Indicators report from the Veracruzan State Cancerology Center
PDF (Español (España))

Keywords

Cancer
Radiotherapy
Brachytherapy
Chemotherapy
Health indicators

Abstract

Introduction. The State  Cancer  Center  (CECan) of the State of Veracruz presents its hospital in- dicators for the evaluation of its services and in this work the indicators of 13 years are reflected of period 2006-2018. Objective. To present a brief vision of the markers traditionally used in the CE- Can of its 13-year productivity, in order to be able to locate itself within the national panorama of the State Cancer Centers dependent on the Mi- nistry of Health in coordination with the National Cancer Institute. Material and method. Retros- pective work carrying out an analysis of the hos- pital indicators of the yearbooks from January 1, 2006 to December 31, 2018. The following were analyzed: consultations, hospital admission and discharge, surgical interventions, hospital occu- pation, radiotherapy, chemotherapy, pathologi- cal studies, blood transfusions and nosocomial infections, laboratory studies, hospital mortality. Results. Most frequent age group 30-49, 65.2% women-34.8% men; morbidity in consultation: breast cancer, cervical cancer, leukemia, lympho- ma, prostate, ovary, digestive organs, endome- trium and testicle. Days of stay 5.2, for every 100 discharges 60 surgeries were performed, patholo- gies treated with radiotherapy: breast cancer, cer- vical cancer, prostate cancer, leukemia, rectum, endometrium. Increase in chemotherapy in 13 years of 16%, average annual nosocomial infec- tions 20.2%, gross mortality in this period of 3.7%, main causes of admission: breast cancer, cervix, hematopoietic neoplasia and digestive organs. Conclusions. This report on hospital indicators could be a mirror of the other cancer centers or services that treat this disease in Mexico, but un- fortunately the reports do not cover the totality of hospital productivity.

https://doi.org/10.25009/rmuv.2020.2.7
PDF (Español (España))

Downloads

Download data is not yet available.